Skip to main content
Caplight Logo









RedCloud Bio

RedCloud Bio

Private
ShanghaiHealthcare & Life Scienceshttp://www.redcloudbio.com/

Last Round

Series B

Extension

May 15, 2023

Total Funding Raised

$29.65M

Company Overview

RedCloud Bio is a biotechnology company that integrates structural pharmacology and computational technologies to discover and develop small molecule drugs for cancer and other severe diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

small molecule therapeuticsdrug discoverynon-small cell lung cancerNSCLCstructural pharmacologycomputational drug discoveryin silico drug designtyrosine kinase inhibitorTKIai-driven drug discoverymolecular dynamicsprecision medicineoncology therapeuticsbiotechdrug resistance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RedCloud Bio Comparables

Compare RedCloud Bio with similar companies based on industry and business-model similarity.

RedCloud Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
J INTS BIO
87%
Eli Lilly and Company
86%
Black Diamond Therapeutics
77%

RedCloud Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMay 15, 2023
Series BJun 17, 2021
Series ANov 30, 2019
SeedJul 1, 2018

RedCloud Bio Investors

Notable investors and investment history

RedCloud Bio investors
InvestorRounds
Kaitai CapitalSeries B
Co-Win VenturesSeries B
Sherpa Healthcare PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors increased 833% MoM.

  • May 15, 2023

    $14.15M raised in Series B Extension round.

RedCloud Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RedCloud Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RedCloud Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range1
Year Founded2022
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?